Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function
| dc.authorid | 0000-0003-1623-3303 | |
| dc.authorid | 0000-0003-1582-6924 | |
| dc.authorid | 0000-0002-2432-9279 | |
| dc.authorid | 0000-0002-0941-4571 | |
| dc.authorid | 0000-0002-4667-3679 | |
| dc.authorid | 0000-0002-4336-6518 | |
| dc.authorid | 0000-0002-3749-2884 | |
| dc.contributor.author | Karaca, Ender | |
| dc.contributor.author | Weitzer, Stefan | |
| dc.contributor.author | Pehlivan, Davut | |
| dc.contributor.author | Shiraishi, Hiroshi | |
| dc.contributor.author | Gogakos, Tasos | |
| dc.contributor.author | Hanada, Toshikatsu | |
| dc.contributor.author | Jhangiani, Shalini N. | |
| dc.date.accessioned | 2025-05-10T19:48:49Z | |
| dc.date.issued | 2014 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | CLP1 is a RNA kinase involved in tRNA splicing. Recently, CLP1 kinase-dead mice were shown to display a neuromuscular disorder with loss of motor neurons and muscle paralysis. Human genome analyses now identified a CLP1 homozygous missense mutation (p. R140H) in five unrelated families, leading to a loss of CLP1 interaction with the tRNA splicing endonuclease (TSEN) complex, largely reduced pretRNA cleavage activity, and accumulation of linear tRNA introns. The affected individuals develop severe motor-sensory defects, cortical dysgenesis, and microcephaly. Mice carrying kinase-dead CLP1 also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons. Our data elucidate a neurological syndrome defined by CLP1 mutations that impair tRNA splicing. Reduction of a founder mutation to homozygosity illustrates the importance of rare variations in disease and supports the clan genomics hypothesis. | |
| dc.description.sponsorship | US National Institute of Neurological Disorders and Stroke (NINDS) [R01NS058529]; US National Human Genome Research Institute (NHGRI) [U54HG006542]; Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research; NINDS [K23NS078056]; DFG [FG885, GRK 1459]; IMBA; Advanced ERC grant; NIAID [1K23AI087821- 01]; Grants-in-Aid for Scientific Research [25460387] Funding Source: KAKEN | |
| dc.description.sponsorship | We thank the patients and families who participated in this study. We thank the CSF/PIF MRI imaging facility at the campus Vienna BioCenter. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS058529 and US National Human Genome Research Institute (NHGRI) grant U54HG006542 to J.R.L.H.S. is supported in part by the fellowship of Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research. W.W. is supported by a K23NS078056 grant from the NINDS. M.G. is supported by grants from the DFG (FG885 and GRK 1459). J.M. and S.W. are supported by IMBA. J.M.P. is supported by an Advanced ERC grant and IMBA. L.M.F. is supported by a Career Development Award (1K23AI087821- 01) from the NIAID. J.R.L. is a paid consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the clinical exome sequencing offered in the Medical Genetics Laboratory. | |
| dc.identifier.doi | 10.1016/j.cell.2014.02.058 | |
| dc.identifier.endpage | 650 | |
| dc.identifier.issn | 0092-8674 | |
| dc.identifier.issn | 1097-4172 | |
| dc.identifier.issue | 3 | |
| dc.identifier.pmid | 24766809 | |
| dc.identifier.scopus | 2-s2.0-84899576549 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 636 | |
| dc.identifier.uri | https://doi.org/10.1016/j.cell.2014.02.058 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/11827 | |
| dc.identifier.volume | 157 | |
| dc.identifier.wos | WOS:000335392100013 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Cell Press | |
| dc.relation.ispartof | Cell | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Cause Pontocerebellar Hypoplasia | |
| dc.subject | Synthetase Mutations | |
| dc.subject | Protein Function | |
| dc.subject | Gene | |
| dc.subject | Disease | |
| dc.subject | Neuropathy | |
| dc.subject | Complex | |
| dc.title | Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










